| Language: [ English ]
| Novel Forensic Research GUIDE FOR AUTHORS Information For Authors Context Novel Forensic Research (NOFOR) is a scientific, open access periodical published with the principles of independent, impartial and double-blind refereeing. The official language of the journal is English and is published four times a year in March, June, September and December. Articles must be written in English and meet the requirements of the journal. All articles to be published in the journal must comply with research and publication ethics. The Novel Forensic Research (NOFOR) journal aims to contribute to the scientific world with the most innovative, cutting-edge, and influential publications in the field of general forensic science. The journal strives for an international authorship and publishes a broad scope of forensic sciences including: Forensic pathology Clinical forensic medicine Forensic psychiatry Forensic toxicology and chemistry (including drugs, alcohol, etc.) Forensic biology (including the identification of hairs and fibers) Forensic genetics Anthropology Criminalistics Document examination Accident investigation Crime scene investigation Explosive Quality assurance Forensic entomology Forensic odontology Digital evidence Gunshot injury, etc. The magazine publishes: 1. Original Research Articles (Regular Papers) 2. Review Articles 3. Case Report 4. Rapid Communications 5. Technical Notes 6. Preliminary Communications 7. Letters to the Editor 8. Commentaries Manuscript Preparation Manuscripts submitted for evaluation should be original and not previously presented or published in any electronic or print medium. If a manuscript was previously presented at a conference or meeting, authors should provide detailed information about the event, including the name, date, and location of the organization. The manuscripts should be prepared in accordance with ICMJE-Recommendations for the Conduct,Reporting, Editing, and Publication of Scholarly Work in Medical Journals (updated in December 2019 – http://www.icmje.org/icmje-recommendations.pdf). Authors are required to prepare manuscripts in accordance with the CONSORT guidelines for randomized research studies, STROBE guidelines for observational original research studies, STARD guidelines for studies on diagnostic accuracy, PRISMA guidelines for systematic reviews and meta-analysis, ARRIVE guidelines for experimental animal studies, and TREND guidelines for non-randomized public behavior. To find the right guideline for your research, please complete the questionnaire by Equator Network here. The style of manuscripts should follow the AMA Manual of Style, 11th Edition. Manuscripts can only be submitted through the journal’s online manuscript submission and evaluation system, available at https://nofor.org submitted via any other medium and submissions by anyone other than one of the authors will not be evaluated. Manuscripts submitted to the journal will first go through a technical evaluation process where the editorial office staff will ensure that the manuscript has been prepared and submitted in accordance with the journal’s guidelines. Submissions that do not conform to the journal’s guidelines will be returned to the submitting author with technical correction requests. Authors are required to submit the following: Copyright Agreement and Acknowledgement of Authorship Formand ICMJE Potential Conflict of Interest Disclosure Form (should be filled in by all contributing authors) during the initial submission. These forms are available for download at https://www.nofor.org Authorship Each person listed as an author should fulfill the authorship criteria recommended by the International Committee of Medical Journal Editors (ICMJE – www.icmje.org). The ICMJE recommends that authorship is based on the following four criteria: Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND Drafting the work or revising it critically for important intellectual content; AND Final approval of the version to be published; AND Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. In addition to being accountable for the parts of the work he/she has done, an author should be able to identify which co-authors are responsible for specific other parts of the work. Also, authors should have confidence in the integrity of the contributions of their co-authors. All those designated as authors should meet all four criteria for authorship, and all who meet the four criteria should be identified as authors. Those who do not meet all four criteria should be acknowledged on the title page of the manuscript. Novel Forensic Research (NOFOR) requires corresponding authors to submit a signed and scanned version of the authorship contribution form (available for download through http://www.nofor.org the initial submission process to act appropriately on authorship rights and to prevent ghost or honorary authorship. If the editorial board suspects a case of “gift authorship,” the submission will be rejected without further review. As part of the submission of the manuscript, the corresponding author should also send a short statement declaring that he/she accepts to undertake all the responsibility for authorship during the submission and review stages of the manuscript. Changes to Authorship Novel Forensic Research (NOFOR) reviews the authorship according to the author’s declaration in the Title Page, thus it is the authors responsibility to send the final order of the complete author names. Requests in the change of authorship (e.g. removal/addition of the authors, change in the order etc) after submission are subject to editorial approval. Editorial Board will investigate this kind of cases and act following COPE flowcharts. Change of authorship requests should be submitted to the Editorial Office with an official letter stating the reasons of the change. The letter must be signed by all authors and include their approval on the change in authorship. If the request is approved by the Editorial Board, authors need to submit a new Copyright Agreement Form according to the final order list. Preparation of the Manuscript Title page: A separate title page should be submitted with all submissions and this page should include: The full title of the manuscript as well as a short title (running head) of no more than 50 characters, Include only full names of the authors directly affiliated with the work. The maximum number of authors is eight for original articles, five for case reports and “How to Do It” articles, three for interesting images, and correspondence. Exceeding numbers will have to be justified to the Editor. Include the name and location of no more than two institutional affiliations where the work was actually done. If more than one department or institution are given, indicate affiliation of each author. Name(s), affiliations, highest academic degree(s), and ORCID IDs of the author(s),• Grant information and detailed information on the other sources of support, Name, address, telephone (including the mobile phone number), and email address of the corresponding author, Acknowledgment of the individuals who contributed to the preparation of the manuscript but who do not fulfill the authorship criteria. ORCID ID The Open Researcher and Contributor ID (ORCID) number of each author must be submitted when creating an account for correspondence. To obtain an ORCID number, please visit https://orcid.org/ Abstract: An abstract should be submitted with all submissions except for Letters to the Editor. The abstract of Research Articles should be structured with subheadings (Aim, Materials and Methods, Results, and Conclusion). Please check Table 1 below for word count specifications.. Keywords: Each submission must be accompanied by a minimum of three to a maximum of five keywords for subject indexing at the end of the abstract. The keywords should be listed in full without abbreviations. The keywords should be selected from the National Library of Medicine, Medical Subject Headings database (https://www.nlm.nih.gov/mesh/MBrowser.html). Manuscript Types Original Articles: Novel Forensic Research accepts original clinical (conducted with healthy subjects or patients) or experimental (human, animal or in-vitro trials) research articles performed in fields of on topics in Arterial, Venous, Lymphatic Disorders and their managements. This is the most important type of article since it provides new information based on original research. Acceptance of original papers will be based upon the originality and importance of the investigation. The main text of original articles should be structured with Introduction, Materials and Methods, Results, and Discussion subheadings. Please check Table 1 for the limitations for Original Articles. Clinical Trials Novel Forensic Research (NOFOR) adopts the ICMJE‘s clinical trial registration policy, which requires that clinical trials must be registered in a publicly accessible registry that is a primary register of the WHO International Trials Registry Platform (ICTRP) or in ClinicalTrials.gov. Instructions for the clinical trials are listed below. Clinical trial registry is only required for the prospective research projects that study the relationship between a health-related intervention and an outcome by assigning people. To have their manuscript evaluated in the journal, author should register their research to a public registry at or before the time of first patient enrollment. Based on most up to date ICMJE recommendations Novel Forensic Research (NOFOR) accepts public registries that include minimum acceptable 24-item trial registration dataset. Authors are required to state a data sharing plan for the clinical trial registration. Please see details under “Data Sharing” section. For further details, please check ICMJE Clinical Trial Policy at http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html Data Sharing Authors are required to provide a data sharing statement for the articles that reports the results of a clinical trial. The data sharing statement should indicate the items below according to the ICMJE data sharing policy: Whether individual deidentified participant data will be shared What data in particular will be shared Whether additional, related documents will be available When the data will be available and for how long By what access criteria will be shared Authors are recommended to check the ICMJE data sharing examples at http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html While submitting a clinical trial to Novel Forensic Research (NOFOR) , Authors are required to make registration to a publicly accessible registry according to ICMJE recommendations and the instructions above. The name of the registry and the registration number should be provided in the Title Page during the initial submission. Data sharing statement should also be stated in the Title Page even the authors do not plan to share it. Reporting Statistical Analysis Statistical analysis to support conclusions is usually necessary. Statistical analyses must be conducted in accordance with international statistical reporting standards (Altman DG, Gore SM, Gardner MJ, Pocock SJ. Statistical guidelines for contributors to medical journals. Br Med J 1983: 7; 1489-93). Information on statistical analyses should be provided with a separate subheading under the Materials and Methods section and the statistical software that was used during the process must be specified. Values for reporting statistical data, such as P values and CIs should be presented and rounded appropriately. P values should be expressed to 2 digits to the right of the decimal point unless the first 2 digits are zeros, in which case 3 digits to the right of the decimal place should be provided (eg, instead of P < .01, report as P = .002). However, values close to .05 may be reported to 3 decimal places because the .05 is an arbitrary cut point for statistical significance (eg, P = .053). P values less than .001 should be designated as P < .001 rather than exact values (eg, P = .000006). Units should be prepared in accordance with the International System of Units (SI). Review Articles: Reviews prepared by authors who have extensive knowledge on a particular field and whose scientific background has been translated into a high volume of publications with a high citation potential are welcomed. These authors may even be invited by the journal. Reviews should describe, discuss, and evaluate the current level of knowledge of a topic in clinical practice and should guide future studies. The main text should contain Introduction, Clinical and Research Consequences, and Conclusion sections. Please check Table 1 for the limitations for Review Articles. Case Reports: Brief descriptions of a previously undocumented disease process, a unique unreported manifestation or treatment of a known disease process, or unique unreported complications of treatment regimens. Case reports should include an adequate number of images and figures. Case reports should be accompanied by “Informed Consent” whether the identity of the patients is disclosed or not. The “Informed Consent Form” is available at https://www.nofor.org Please check Table 1 for the limitations for Case Report. Letters to the Editor: This type of manuscript discusses important parts, overlooked aspects, or lacking parts of a previously published article. Articles on subjects within the scope of the journal that might attract the readers’ attention, particularly educative cases, may also be submitted in the form of a “Letter to the Editor.” Readers can also present their comments on the published manuscripts in the form of a “Letter to the Editor.” Abstract, Keywords, and Tables, Figures, Images, and other media should not be included. The text should be unstructured. The manuscript that is being commented on must be properly cited within this manuscript. Please check Table 1 for the limitations for Letter to Editor. References: Both in-text citations and the references must be prepared according to the AMA Manual of Style 11th Edition. While citing publications, preference should be given to the latest, most up-to-date publications. If an ahead-of-print publication is cited, the DOI number should be provided. Authors are responsible for the accuracy of references. Journal titles should be abbreviated in accordance with the journal abbreviations in Index Medicus/ MEDLINE/PubMed. When there are four or fewer authors, all authors should be listed. If there are five or more authors, the first three authors should be listed followed by “et al.” In the main text of the manuscript, references should be cited using Arabic numbers in parentheses. The reference styles for different types of publications are presented in the following examples. References should be limited to 10 for letters to the editor, 20 for case reports, 40 for clinical/experimental reports and review articles. Journal abbreviations should conform to the style used in the Cumulated Index Medicus (please see www.icmje.org). Journal articles, books, web pages, conference presentations, newspapers, audio-visual sources like CDs and DVDs, articles pending for publication, theses, and dissertations can be used as references. Please check Table 1 for the limitations for Original Articles. Reference Format for Journal Articles: Authors’ initials, surnames and names, article titles, journal titles, date, volume, number and pagination must be indicated. E.g.: For Journal Articles Celbis O, Karakoc Y, Ozdemir B, et al. Investigation of lead mobilization from the buckshot residues to the critical organs. Biol Trace Elem Res. 2011;143:688-94. For Book References DiMaio WJ, DiMaio D. Time of death. In: Forensic Pathology. 2nd edition. CRC Press, London, 2001;21-42. Madea B, Henssge C. Timing of death. In: Payne-James J, Busuttil A, Smock W, eds, Forensic Medicine: Clinical Pathological Aspects. London: Greenwich Medical Media Ltd. 2003;91-114. For Internet References Beware: Toy Noise may be too loud for kids. http://hearingaiddocs. wordpress.com/tag/loud-toys access date 22.04.2013 For Congress Presentations Brandes U, Wagner D. A Bayesian paradigm for dynamic graph layout. 11th International Symposium on Graph Drawing, 12-15 November 2003. New York, USA, 236-47. For Newspaper References Susan S. How to prevent breast cancer. Australian 23 October 2003. For CD-ROM References The Oxford English Dictionary [CD-ROM]. 2nd ed. New York: Oxford University Press; 1992. For Accepted Articles Kaya A, Aktas EO. Perception differences between in violence against child. Med-Science. Published Online: Nov 19, 2013. For Thesis Karakoc Y. Biological effect of direct electrical current in essential (idiopathic) hyperhidrosis. Ph.D. thesis, Istanbul University, Istanbul, 1996. In case of use of a previously published table, figure or illustration, reference of the material must be cited in reference list. Tables Tables should be included in the main document, presented after the reference list, and they should be numbered consecutively in the order they are referred to within the main text. A descriptive title must be placed above the tables. Abbreviations used in the tables should be defined below the tables by footnotes (even if they are defined within the main text). Tables should be created using the “insert table” command of the word processing software and they should be arranged clearly to provide easy reading. Data presented in the tables should not be a repetition of the data presented within the main text but should be supporting the main text. Include written permission from both the author and the publisher to reproduce any previously published table(s) in both print and electronic media. Figures and Figure Legends Figures, graphics, and photographs should be submitted as separate files (in TIFF or JPEG format) through the submission system. The files should not be embedded in a Word document or the main document. When there are figure subunits, the subunits should not be merged to form a single image. Each subunit should be submitted separately through the submission system. Images should not be labeled (a, b, c, etc.) to indicate figure subunits. Thick and thin arrows, arrowheads, stars, asterisks, and similar marks can be used on the images to support figure legends. Like the rest of the submission, the figures too should be blind. Any information within the images that may indicate an individual or institution should be blinded. The minimum resolution of each submitted figure should be 300 DPI. To prevent delays in the evaluation process, all submitted figures should be clear in resolution and large in size (minimum dimensions: 100 × 100 mm). Figure legends should be listed at the end of the main document. All acronyms and abbreviations used in the manuscript should be defined at first use, both in the abstract and in the main text. The abbreviation should be provided in parentheses following the definition. When a drug, product, hardware, or software program is mentioned within the main text, product information, including the name of the product, the producer of the product, and city and the country of the company (including the state if in USA), should be provided in parentheses in the following format: “Discovery St PET/CT scanner (General Electric, Milwaukee, WI, USA)” All references, tables, and figures should be referred to within the main text, and they should be numbered consecutively in the order they are referred to within the main text. Limitations, drawbacks, and the shortcomings of original articles should be mentioned in the Discussion section before the conclusion paragraph. Revisions Authors must indicate the changes on the main text while resubmitting revised files, and also answers to each reviewer suggestions separately must be included in the letter. Page and line number of corrections must be included as well. Revised form of manuscripts must be sent to journal within 30 days, otherwise revision option may be canceled. Warning letter will be sent and then after 15 days, manuscript will be rejected. If authors need extension of time for revisions anyhow, the journal must be informed before the deadline of revision. Proofs and Publication DOI Number Once a manuscript has been accepted for publication, it goes through a copy-editing process by professional language editors to ensure that it is clear and well-written. This process may involve correcting grammar, punctuation, and formatting errors, as well as making changes to improve the overall clarity and readability of the manuscript. After the copy-editing process is complete, the manuscript is published online as an “ahead-of-print” publication, which means that it is available to readers before it is included in a scheduled issue of the journal. This allows readers to access the latest research as soon as it becomes available. Before the manuscript is officially published, the corresponding author is sent a PDF proof of the accepted manuscript for review. The corresponding author is asked to review the proof and approve it for publication within a specified time period, typically 2 days. This is an important step in the publication process, as it allows the author to catch any errors or make any final changes before the manuscript is published. Acceptance The submitted papers will be published upon the editorial board’s approval. Rejected manuscripts and their attachments (photographs, tables, graphics, and diskettes) will not be returned unless otherwise requested by the authors.
Prof. Dr. Osman CELBİŞ Editor in Chief of Novel Forensic Research (NOFOR) Department of Forensic Medicine Publisher: Effect Publishing & Agency | |||||||||||||||||||||||||
| SUBMIT YOUR MANUSCRIPT NOW | ||||||||||||||||||||||||||
